Creo Fenestrated
Payments companies reported to CMS as associated with Creo Fenestrated. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Creo Fenestrated, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Creo Fenestrated
These are the largest totals companies reported as associated with Creo Fenestrated. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Sabino Dagostino | Ladson, SC | Neurological Surgery | $26,141.75 |
| Rohit Vasan | Tampa, FL | Neurological Surgery | $26,011.71 |
| Rory Mayer | Dallas, TX | Neurological Surgery | $320.90 |
| Tonia Collins | Elkhart, IN | Family | $208.15 |
| David Masel | Plano, TX | Neurological Surgery | $200.00 |
| Matthew Geck | Austin, TX | Orthopaedic Surgery of The Spine | $175.20 |
| Michael Duffy | Mansfield, TX | Orthopaedic Surgery of The Spine | $163.47 |
| Steven Vetter | Fairfax, VA | Foot & Ankle Surgery | $163.40 |
| Aaron Dumont | New Orleans, LA | Neurological Surgery | $161.12 |
| Carl Youssef | Panama City, FL | Neurological Surgery | $159.38 |
Prescribed Creo Fenestrated?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.